The polypeptide antifungal agent (X-5079C): further studies in 39 patients.
D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D002177:Candidiasis / Q000188:drug therapy*; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003047:Coccidioidomycosis / Q000188:drug therapy*; D005260:Female; D006660:Histoplasmosis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D008271:Mycetoma / Q000188:drug therapy*; D009181:Mycoses / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D013174:Sporotrichosis / Q000188:drug therapy*
D000935:Antifungal Agents; D010455:Peptides